MADDALONI, ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 2.816
EU - Europa 1.045
AS - Asia 632
SA - Sud America 31
AF - Africa 28
OC - Oceania 14
Totale 4.566
Nazione #
US - Stati Uniti d'America 2.761
IT - Italia 523
SG - Singapore 326
SE - Svezia 203
IN - India 133
CN - Cina 110
RU - Federazione Russa 67
CA - Canada 49
DE - Germania 41
FI - Finlandia 30
IE - Irlanda 26
UA - Ucraina 26
ID - Indonesia 25
RO - Romania 21
TG - Togo 21
BR - Brasile 20
FR - Francia 20
GB - Regno Unito 19
BG - Bulgaria 18
AU - Australia 13
AT - Austria 11
NL - Olanda 10
AR - Argentina 8
ES - Italia 7
BE - Belgio 6
KR - Corea 6
MX - Messico 6
MY - Malesia 6
PL - Polonia 6
HK - Hong Kong 5
TR - Turchia 5
SY - Repubblica araba siriana 4
CL - Cile 3
IQ - Iraq 3
TH - Thailandia 3
AL - Albania 2
DK - Danimarca 2
HU - Ungheria 2
NG - Nigeria 2
PH - Filippine 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SN - Senegal 1
TZ - Tanzania 1
Totale 4.566
Città #
Fairfield 527
Rome 259
Woodbridge 225
Singapore 221
Seattle 210
Ashburn 198
Houston 189
Cambridge 175
Chandler 162
Wilmington 160
Ann Arbor 86
Princeton 77
Millbury 68
Santa Clara 67
Beijing 65
San Paolo di Civitate 58
Lawrence 57
San Diego 55
Plano 46
Ottawa 31
Andover 26
Dublin 26
New York 26
Jakarta 25
Lomé 21
Sofia 18
Boston 17
Helsinki 17
Moscow 16
Toronto 15
Norwalk 14
Stockholm 13
Yubileyny 13
Boardman 12
Nuremberg 12
Sydney 12
Milan 10
Des Moines 9
Naples 9
San Mateo 9
Latina 8
Dearborn 7
Madrid 7
Bühl 6
Hefei 6
Induno Olona 6
London 6
Mannheim 6
Munich 6
Brussels 5
Falkenstein 5
Federal 5
Fremont 5
Hong Kong 5
Istanbul 5
Los Angeles 5
Belo Horizonte 4
Dallas 4
Messina 4
Venafro 4
Bangkok 3
Barrie 3
Chicago 3
Chieti 3
Geumjeong-gu 3
Guangzhou 3
Gwanak-gu 3
Hebei 3
Lingolsheim 3
Mexico City 3
Molfetta 3
Nanjing 3
Southend 3
Târgu Mureş 3
Vienna 3
Warsaw 3
Albuquerque 2
Ardea 2
Arezzo 2
Bedong 2
Catanzaro 2
Copenhagen 2
Fontanellato 2
Fort Myers 2
Fort Worth 2
Hyderabad 2
Innsbruck 2
Ipoh 2
Johannesburg 2
Kirkuk 2
Kunming 2
Lappeenranta 2
Livorno 2
Menlo Park 2
Monte Porzio Catone 2
Nagpur 2
Nanchang 2
Pagani 2
Pomigliano d'Arco 2
Santarcangelo di Romagna 2
Totale 3.461
Nome #
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 119
Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial 112
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) 98
Adult-onset autoimmune diabetes: current knowledge and implications for management 96
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes 93
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis 92
Wrist circumference is a biomarker of adipose tissue dysfunction and cardiovascular risk in children with obesity 86
Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement 84
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity 81
Frailty and geography: Should these two factors be added to the ABCDE contemporary guide to diabetes therapy? 79
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 78
In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes 75
Osteocalcin and sclerostin. Background characters or main actors in cardiovascular disease? 75
New strategy to study the impact of ethnicity on diabetic neuropathy 74
Diabetes-related autoantibodies in children with acute lymphoblastic leukemia 72
Combination immunotherapies for type 1 diabetes mellitus 72
Chitotriosidase Activity Is Inversely Associated with Diastolic Blood Pressure and HbA1c but Not with Arterial Stiffness in Patients with Type 2 Diabetes without Complications 72
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence? 70
Comment on: "Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results" 70
Comparison of lipid-lowering medications and risk for cardiovascular disease in diabetes 69
Continuous glucose monitoring and robot surgery of an insulinoma: a case report and review of the literature 68
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies 67
Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy 67
Why only macro and not micro in type 2 diabetes? Time to change the goals of clinical trials in diabetes 67
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism 67
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study 67
Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. 66
Why China guidelines for type 2 diabetes represent an opportunity for treating this disease 66
Bone Microarchitecture in Type 1 Diabetes: It Is Complicated 66
Adult-onset autoimmune diabetes in 2020: an update 66
Long-term Risk of Cardiovascular Disease in Individuals with Latent Autoimmune Diabetes of Adults (UKPDS 85) 65
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes 64
Bone health in subjects with type 1 diabetes for more than 50 years 63
Prevention of atherothrombotic events in patients with diabetes mellitus. From antithrombotic therapies to new-generation glucose-lowering drugs 63
Cardiovascular effects of SGLT-2 inhibitors: what we have learned from cardiovascular outcome trials and what we still need to understand 63
High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja 63
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes 61
Vitamin D and Diabetes Mellitus 61
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: a 24 months follow-up study 61
Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: A case report 60
Diabetes: the disease of the 10 D 60
SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes) 59
Risk factors for fragility fractures in type 1 diabetes 59
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 58
Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules 58
PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life 58
Correction to: "H" for heterogeneity in the algorithm for type 2 diabetes management 58
Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial 55
Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function 55
Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis 54
Insulin decreases atherosclerosis by inducing endothelin receptor B expression 53
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes. A cross-sectional study 53
Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease 52
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes 52
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86) 51
In vivo corneal confocal microscopy in diabetes: Where we are and where we can get 49
Development of a clinical risk score to predict death in patients with COVID-19 49
Serum 25-OH Vitamin D in relation to Bone Mineral Density and Bone Turnover 47
Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease 47
New technologies aiding dietary programmes for weight control: the oral glucose spray 46
null 46
Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis 44
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective 42
Adult-onset autoimmune diabetes 41
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome 41
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 39
null 38
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study 37
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 37
Risk factors and predictive biomarkers of early cardiovascular disease in obese youth 36
Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does money matter? 36
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes 35
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes 35
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics 34
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study. The CoVaDiab study I 33
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 30
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: a 12‐month, randomized, comparator‐controlled pilot study 30
Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment. A Pilot Study 25
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications 25
SGLT-2 inhibitors on top of current pharmacological treatments for heart failure: a comparative review on outcomes and cost effectiveness 25
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 25
Tipo 1 e LADA in crescita: prevenzione e assistenza ottimale 24
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study 23
Il ruolo del biostatistico nella preparazione conduzione e monitoraggio delle sperimentazioni cliniche 23
The vicious circle of left ventricular dysfunction and diabetes: from pathophysiology to emerging treatments 23
null 17
Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication 17
null 14
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes 14
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA 14
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials 14
Serum chitotriosidase in postmenopausal women with severe osteoporosis 14
IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes 13
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92) 13
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis 12
Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy 12
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review 10
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study 10
Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules 8
Effects of covid-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy 7
Totale 5.047
Categoria #
all - tutte 17.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020419 0 0 0 0 0 0 0 124 109 79 59 48
2020/2021700 48 34 33 18 7 38 13 19 73 171 128 118
2021/2022851 13 16 47 54 109 49 34 77 85 67 162 138
2022/2023899 178 170 66 94 58 92 28 68 60 25 45 15
2023/2024479 35 38 13 25 48 61 18 25 7 80 55 74
2024/2025715 33 88 107 86 78 125 179 19 0 0 0 0
Totale 5.083